Cardiometabolic diseases – Ping Chen research group

We work on data-driven research in human cardiometabolic diseases.


We aim to integrate longitudinal patient data, cutting-edge multi-omics technologies, and novel computational approaches to monitor individual disease progression and dissect the underlying disease-driving mechanisms. In particular, we are interested in the roles of immune cells (macrophages, monocytes, dendritic cells, etc.) and RNA splicing-centric transcriptional regulation in disease progression.

Currently, we focus on obesity and its associated metabolic diseases, especially non-alcoholic fatty liver disease and diabetes.


Selected publications

Research techniques

  • Single-cell omics, Spatial omics
  • Mass spectrometry
  • Bioinformatics
  • Artificial intelligence.
Bioinformatics and Systems Biology (methods development, see 10203) Cardiac and Cardiovascular Systems Endocrinology and Diabetes Gastroenterology and Hepatology Immunology in the medical area
Content reviewer: